Tetrandrine inhibits aldosterone synthesis by covalently targeting CYP11A1 to attenuate hypertension

MLA

Simeng Chu, et al. “Tetrandrine Inhibits Aldosterone Synthesis by Covalently Targeting CYP11A1 to Attenuate Hypertension.” Frontiers in Pharmacology, vol. 15, June 2024. EBSCOhost, https://doi.org/10.3389/fphar.2024.1387756.

APA

Simeng Chu, Wei Yang, Yujie Lu, Junjie Li, Jiamin Peng, Wenjuan Liu, Min Jiang, & Gang Bai. (2024). Tetrandrine inhibits aldosterone synthesis by covalently targeting CYP11A1 to attenuate hypertension. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1387756

Chicago

Simeng Chu, Wei Yang, Yujie Lu, Junjie Li, Jiamin Peng, Wenjuan Liu, Min Jiang, and Gang Bai. 2024. “Tetrandrine Inhibits Aldosterone Synthesis by Covalently Targeting CYP11A1 to Attenuate Hypertension.” Frontiers in Pharmacology 15 (June). doi:10.3389/fphar.2024.1387756.